Hazardous Drug (HD) Wipe Sampling

U.S. Micro-Solutions is partnering with Quess360 Pharmacy Solutions to offer targeted HD Wipe Sampling for USP <800> compliance - Safer surfaces, Smarter monitoring!

USP <800> states the following: Environmental wipe sampling for HD surface residue should be performed routinely (e.g., initially as a benchmark and at least every 6 months, or more often as needed, to verify containment).

SOME RECOMMENDED AREAS to be sampled:

  • Front grille within the C-PEC
  • Cart beside the C-PEC
  • Passthrough
  • Floor in front of the C-PEC
  • Armrest of a patient treatment chair

Hazardous Drugs Tested

Groups of drugs Limit of detection
(ng/cm2)
Group 1F
fluorouracil 0.0089
Group 1M
methotrexate 0.0044
Group 2
cytarabine 0.0111
dacarbazine 0.0022
DOXOrubicin 0.0444
epirubicin 0.0444
gemcitabine 0.0022
melphalan 0.0044
Group 3
cyclophosphamide 0.0022
DOCEtaxel 0.1333
etoposide 0.0089
ifosfamide 0.0022
irinotecan 0.0089
methotrexate 0.0044
PACLitaxel 0.0444
PEMEtrexed 0.0089
topotecan 0.0044
vinBLAStine 0.0444
vinCRIstine 0.0444
Group 4
Platins (CISplatin, oxaliplatin, CARBOplatin) 0.0022
Group 5
All hazardous drugs in groups 1 to 4
Group 6
a. CARBOplatin
b. CISplatin
c. Cyclophosphamide
d. Fluorouracil
e. Gemcitabine
f. Ifosfamide
g. Methotrexate
h. Oxaliplatin
i. PACLitaxel

Build a sampling kit tailored to your needs

Hormones Chemo drugs
Select 1, 3 or all 5 Group 1F Group 1M Group 2 Group 3 Group 4 Group 5 Group 6
Estradiol
Estriol
Estrone
Progesterone
Testosterone
Fluorouracil (5-FU) Methotrexate Includes:
Cytarabine
Dacarbazine
DOXOrubicin
Epirubicin
Gemcitabine
Melphalan
Includes:
Cyclophosphamide
DOCetaxel
Etoposide
Ifosfamide
Irinotecan
Methotrexate
PACLitaxel
Pemetrexed
Topotecan
VinBLASTine
VinCRIStine
Includes:
CARBOplatin
CISplatin
Oxaliplatin
Includes all 21 HDs listed from Group 1F, 1M, 2, 3, 4 Includes:
CARBOplatin
CISplatin
Cyclophosphamide
Fluorouracil
Gemcitabine
Ifosfamide
Methotrexate
Oxaliplatin
PACLitaxel